These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8213329)

  • 1. Role of serology in monitoring treatment for Helicobacter pylori infection in elderly patients.
    Safe AF; Warren B; Corfield A; McNulty CA; Watson B; Mountford RA; Read A
    Age Ageing; 1993 Jul; 22(4):256-9. PubMed ID: 8213329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term serological surveillance after treatment of Helicobacter pylori infection.
    Veenendaal RA; Peña AS; Meijer JL; Endtz HP; van der Est MM; van Duijn W; Eulderink F; Kreuning J; Lamers CB
    Gut; 1991 Nov; 32(11):1291-4. PubMed ID: 1752457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
    Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G
    Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
    Perri F; Festa V; Clemente R; Villani MR; Quitadamo M; Caruso N; Bergoli ML; Andriulli A
    Am J Gastroenterol; 2001 Jan; 96(1):58-62. PubMed ID: 11197288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Triple-therapy treatment during 1 month versus 2 weeks in gastroduodenal disease due to Helicobacter pylori in children].
    Cilleruelo Pascual ML; Urruzuno Tellería P; Román Riechman E; Medina Benítez E; Manzanares López-Manzanares J; Echávarri Olavarría F; Molina Arias M
    An Esp Pediatr; 1996 May; 44(5):456-60. PubMed ID: 8796956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intragastric acidity on Helicobacter pylori eradication with bismuth-metronidazole-amoxicillin.
    Chang CS; Yang CY; Wong FN; Chen GH; Lien HC; Yeh HZ; Poon SK
    Hepatogastroenterology; 1999; 46(28):2713-7. PubMed ID: 10522070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.
    Choi J; Jang JY; Kim JS; Park HY; Choe YH; Kim KM
    J Korean Med Sci; 2006 Dec; 21(6):1037-40. PubMed ID: 17179683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
    Zala G; Schwery S; Giezendanner S; Flury R; Wüst J; Meyenberger C; Wirth HP
    Schweiz Med Wochenschr; 1996 Feb; 126(5):153-8. PubMed ID: 8685685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer.
    Carpintero P; Blanco M; Pajares JM
    Clin Infect Dis; 1997 Nov; 25(5):1032-7. PubMed ID: 9402352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of serology in determining Helicobacter pylori eradication after therapy.
    Fallone CA; Loo VG; Barkun AN
    Can J Gastroenterol; 1998 Mar; 12(2):117-24. PubMed ID: 9559206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.
    Marzio L; Angelucci D; Grossi L; Diodoro MG; Di Campli E; Cellini L
    Am J Gastroenterol; 1998 Feb; 93(2):223-6. PubMed ID: 9468247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up and serological study after triple therapy of Helicobacter pylori-associated duodenal ulcer.
    Wang WM; Chen CY; Jan CM; Chen LT; Perng DS; Lin SR; Liu CS
    Am J Gastroenterol; 1994 Oct; 89(10):1793-6. PubMed ID: 7942669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori.
    Kosunen TU; Seppälä K; Sarna S; Sipponen P
    Lancet; 1992 Apr; 339(8798):893-5. PubMed ID: 1348298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
    Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
    Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified sequential therapy vs quadruple therapy as initial therapy in patients with Helicobacter infection.
    Liao XM; Nong GH; Chen MZ; Huang XP; Cong YY; Huang YY; Wu BH; Wei JQ
    World J Gastroenterol; 2015 May; 21(20):6310-6. PubMed ID: 26034367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.